Company:

Amedisys Home Health Services

Role:

Financial Advisor

Transaction:

Acquisition of Tender Loving Care, Inc.

Closing Date:

March 27, 2008

Background:

Amedisys is one of the nation’s largest providers of home health and hospice services to Medicare beneficiaries. The company delivers a wide range of health-related services in the home to individuals who may be recovering from surgery, have chronic disability or need assistance with the essential activities of daily living.

Raymond James’ Role:

Raymond James advised Amedisys (NASDAQ: AMED) in the company’s acquisition of TLC Health Care Services, a privately owned home health and hospice provider. TLC has 92 home health and 11 hospice agencies located in 22 states and the District of Columbia and is being sold by Arcapita, an Atlanta-based private equity firm.

Raymond James provided a full range of advisory services including: (i) negotiation and structuring of the initial letter of intent and definitive stock purchase agreement, (ii) managing and coordinating an extensive due diligence process; (iii) assisting Amedisys in developing and refining its detailed projection model and supporting analyses for distribution to potential underwriters; (iv) developing and updating transaction overview and valuation materials for the Amedisys board of directors; and (v) advising management on market communication strategy.

Raymond James previously served as lead manager for the Amedisys’ $124.5 million follow-on offering in November 2006 and $75.9 million follow-on offering in September 2004, and also advised the company in their acquisition of Housecall Medical Resources, the company’ largest prior to TLC. John Ransom covers the company from a research standpoint, with Raymond James as a top trader of Amedisys equity.

On February 19, 2008, Amedisys announced it had signed a definitive agreement to acquire TLC for $395 million in cash using proceeds from a new $500 million acquisition credit facility. Amedisys now has over 480 home health agencies in 35 states and Puerto Rico with TTM revenue of over $1 billion. The transaction closed on March 27th, 2008.